Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,947
datasets available to search
ShareScore release 0.9.0
Dataset results
1,947 results for “Proposals”
Supplementary material 2 from: Zulian G, La Notte A (2022) How to account for nature-based tourism in Europe. An operational proposal. One Ecosystem 7: e89312. https://doi.org/10.3897/oneeco.7.e89312
SEEA-EA online supplement ecosystem services logic chain
Supplementary material 3 from: Zulian G, La Notte A (2022) How to account for nature-based tourism in Europe. An operational proposal. One Ecosystem 7: e89312. https://doi.org/10.3897/oneeco.7.e89312
Nature-based recreation biophysiscal model
FIGURE 6 in A new species of Coreodrassus Paik, 1984 from China, with proposal of a new combination (Araneae: Gnaphosidae)
FIGURE 6. Female genitalia of Coreodrassus murphyi sp. n., in ventral (A) and dorsal (B) view.
Supplementary material 1 from: Zhao H, Vlasák J, Yuan Y (2023) Outline, phylogenetic and divergence times analyses of the genus Haploporus (Polyporales, Basidiomycota): two new species are proposed. MycoKeys 98: 233-252. https://doi.org/10.3897/mycokeys.98.105684
The supplementary materilas in this study
Fig. 8. Proposed biosynthetic pathway for compounds 1, 5, 9, 12, 13 and 16 in Sesquiterpenoids and furan derivatives from the Orychophragmus violaceus (L.) O.E. Schulz endophytic fungus Irpex lacteus OV38
Fig. 8. Proposed biosynthetic pathway for compounds 1, 5, 9, 12, 13 and 16.
Fig. 5. The proposed biosynthetic pathways for 1–6 and 12–15 in Diverse gallotannins with α-glucosidase and α-amylase inhibitory activity from the roots of Euphorbia fischeriana steud.
Fig. 5. The proposed biosynthetic pathways for 1–6 and 12–15.
Fig. 6. The proposed biosynthetic pathways for 7–11 in Diverse gallotannins with α-glucosidase and α-amylase inhibitory activity from the roots of Euphorbia fischeriana steud.
Fig. 6. The proposed biosynthetic pathways for 7–11.
Fig. 4. Proposed fragmentation pathway for compound 3 in Cruciasides C-G, monoterpenoid glycosides from Cruciata articulata
Fig. 4. Proposed fragmentation pathway for compound 3; ESI negative mode.
Fig. 5. Proposed biosynthetic pathway for compounds 1–12 in Immunosuppressive gentianellane-type sesterterpenoids from the traditional Uighur medicine Gentianella turkestanorum
Fig. 5. Proposed biosynthetic pathway for compounds 1–12.
Fig. 5. Proposed biosynthetic pathways for 1 in Xylarinaps A-E, five pairs of naphthalenone derivatives with neuroprotective activities from Xylaria nigripes
Fig. 5. Proposed biosynthetic pathways for 1.
Fig. 5. Proposed biosynthetic pathway for 1 in Euphorfinoids E-L: Diterpenoids from the roots of Euphorbia fischeriana with acetylcholinesterase inhibitory activity
Fig. 5. Proposed biosynthetic pathway for 1.
Fig. 10. Proposed biogenetic pathway for compounds 1–13 in Prenylated C -C derivatives from the stems and branches of Illicium ternstroemioides A. C. Smith with antiviral activity
Fig. 10. Proposed biogenetic pathway for compounds 1–13.
Block diagram of the proposed method
SciDraw upload
Fig. 4. Proposed biosynthetic pathway for compounds 1 and 2 in Heterodimers with a cucurbitane-type triterpenoid skeleton from the branches of Elaeocarpus dubius
Fig. 4. Proposed biosynthetic pathway for compounds 1 and 2.
Figs 12–14 in Proposal of Karliella gen. n. for the Afrotropical 'Pegomya' sexpunctata Karl, 1935 (Diptera: Anthomyiidae), a possible kleptoparasite of dung-breeding beetles
Figs 12–14. Karliella sexpunctata (Karl): (12) male sternites III–V and pregenital segments VI–VIII; (13, 14) male sternite V and pregenital segments VI–VIII, right and left lateral views. Scale bars = 0.25 mm.
FIGURE 3 in Some superfluous names recently proposed involving the Sino-Himalayan Anemone rupestris (Ranunculaceae)
FIGURE 3. Holotype (A) and isotype (B) sheets of Anemone rupestris subsp. rupestris var. latifolia.
Safety and Efficacy Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease
ClinicalTrials.gov study NCT00528840. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease
ClinicalTrials.gov study NCT00528424. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD
ClinicalTrials.gov study NCT01163786. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Proposal for a New Classification of Secondary Cleft Lip and Nose Deformities in Repaired Unilateral Cleft Lip
ClinicalTrials.gov study NCT04972370. IPD Sharing: Not stated. Countries: 0. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.